OPT — Opthea Income Statement
0.000.00%
HealthcareAdventurousMicro Cap
Annual income statement for Opthea, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.069 | 0.091 | 0.108 | 0.125 | 0.025 |
Cost of Revenue | |||||
Gross Profit | -0.36 | -0.07 | -0.058 | — | — |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 39.7 | 96.7 | 150 | 192 | 170 |
Operating Profit | -39.7 | -96.6 | -150 | -192 | -170 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -50.3 | -99.1 | -148 | -230 | -170 |
Provision for Income Taxes | |||||
Net Income After Taxes | -45.3 | -92.8 | -143 | -220 | -163 |
Net Income Before Extraordinary Items | |||||
Net Income | -45.3 | -92.8 | -143 | -220 | -163 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -45.3 | -92.8 | -143 | -220 | -163 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.123 | -0.229 | -0.28 | -0.345 | -0.133 |